Opportunity for severe and critical COVID-19 pneumonia treatment with corticosteroids: a retrospective cohort study
The early administration of corticosteroid therapy has been shown to significantly improve the prognosis of COVID-19 pneumonia patients, promoting recovery with significant clinical significance. Our recommendation for the administration of corticosteroid therapy is to be applied on the 6th-9th day of persisting unrelieved symptoms of COVID-19 pneumonia.
Authors
- Liang Zong (ORCID: https://orcid.org/0000-0003-4139-4571)
- Huadong Zhu (ORCID: https://orcid.org/0000-0002-1592-3188)
- Shengyong Xu (ORCID: https://orcid.org/0000-0001-9567-5980)
- Chen Fan (ORCID: https://orcid.org/0009-0001-1582-8033)
- Yan Li
- Jun Xu (ORCID: https://orcid.org/0009-0003-5253-1567)
Institutions
- Beijing Tongren Hospital (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21037/jtd-24-329
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39